Patents by Inventor Matthew D. LYNES

Matthew D. LYNES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating diabetes, hepatitis, and/or inflammatory liver disease
    Publication number: 20240025981
    Abstract: Disclosed herein are uses of inhibitor of extracellular human metallothionein (MT) to treat a disorder selected from the group consisting of diabetes, pre-diabetes, impaired glucose tolerance, hepatitis, and/or inflammatory liver disease, and compositions containing extracellular human MT.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 25, 2024
    Inventors: Michael A. LYNES, Yu-Hua TSENG, Matthew D. LYNES
  • Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety
    Patent number: 11866488
    Abstract: Disclosed herein are compositions including an inhibitor of extracellular human metallothionein (MT) and a pancreatic targeting moiety linked to the inhibitor of extracellular human MT.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: January 9, 2024
    Assignees: UNIVERSITY OF CONNECTICUT, JOSLIN DIABETES CENTER, INC.
    Inventors: Michael A. Lynes, Yu-Hua Tseng, Matthew D. Lynes
  • METHODS FOR TREATING DIABETES, HEPATITIS, AND/OR INFLAMMATORY LIVER DISEASE
    Publication number: 20200369757
    Abstract: Disclosed herein are uses of inhibitor of extracellular human metallothionein (MT) to treat a disorder selected from the group consisting of diabetes, pre-diabetes, impaired glucose tolerance, hepatitis, and/or inflammatory liver disease, and compositions containing extracellular human MT.
    Type: Application
    Filed: January 17, 2019
    Publication date: November 26, 2020
    Inventors: Michael A. LYNES, Yu-Hua TSENG, Matthew D. LYNES